Works matching IS 10073639 AND DT 2022 AND VI 32 AND IP 11
1
- China Oncology, 2022, v. 32, n. 11, p. 1121, doi. 10.19401/j.cnki.1007-3639.2022.11.011
- Article
2
- China Oncology, 2022, v. 32, n. 11, p. 1074, doi. 10.19401/j.cnki.1007-3639.2022.11.005
- Article
3
- China Oncology, 2022, v. 32, n. 11, p. 1105, doi. 10.19401/j.cnki.1007-3639.2022.11.009
- Article
4
- China Oncology, 2022, v. 32, n. 11, p. 1098, doi. 10.19401/j.cnki.1007-3639.2022.11.008
- Article
5
- China Oncology, 2022, v. 32, n. 11, p. 1091, doi. 10.19401/j.cnki.1007-3639.2022.11.007
- Article
6
- China Oncology, 2022, v. 32, n. 11, p. 1084, doi. 10.19401/j.cnki.1007-3639.2022.11.006
- 王 乾;
- 张 静;
- 郁成礼;
- 包龙龙;
- 蔡 旭;
- 蒋文华;
- 黄 丹;
- 盛伟琪;
- 朱晓丽;
- 周晓燕;
- 柏乾明
- Article
7
- China Oncology, 2022, v. 32, n. 11, p. 1115, doi. 10.19401/j.cnki.1007-3639.2022.11.010
- 郜 意;
- 康茗贻;
- 王 辉;
- 胥 婧;
- 石 月;
- 陶 祥;
- 马凤华;
- 谭灏文;
- 康 玉;
- 徐丛剑
- Article
8
- China Oncology, 2022, v. 32, n. 11, p. 1065, doi. 10.19401/j.cnki.1007-3639.2022.11.004
- Article
9
- China Oncology, 2022, v. 32, n. 11, p. 1049, doi. 10.19401/j.cnki.1007-3639.2022.11.003
- 石 月;
- 陈奕清;
- 丁景新;
- 宁 燕;
- 汪 清;
- 马凤华;
- 谭灏文;
- 康 玉
- Article